Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?

To: lwd who wrote (1458)	1/25/2001 11:21:13 PM
From: Jon Koplik	Respond to of 1728

To all - details of 2/5/01 conference call. Affymetrix to Host Conference Call to Announce Fourth Quarter And 2000 Year-End Results SANTA CLARA, Calif., Jan. 19 /PRNewswire/ -- Affymetrix, Inc., (Nasdaq: AFFX) announced today that it will release fourth quarter and year-end results for 2000 after close of the stock market on Monday, February 5, 2001. Company management will also host a conference call at 2:00 p.m. PST on Monday, February 5 to discuss Affymetrix' results and provide guidance for the year 2001. The dial in number for domestic callers will be 800-280-2151 and for international callers will be 415-904-2425, passcode 1959. A replay of the conference call will be available from 4:00 p.m. PST on February 5 until 4:00 p.m. PST on February 12. The replay number for domestic callers will be 800-633-8284, and for international callers will be 858-812-6440, reservation number 17729416. A live Webcast of the conference call and a replay will also be available at affymetrix.com . The conference call, replay and Webcast are open to all interested parties.

To: lwd who wrote (1458)	1/26/2001 6:21:25 AM
From: nigel bates	Read Replies (1) \| Respond to of 1728

I would have posted the AFFX rebuttal, but it came after I went to bed. I'm a little confused by this - The Court found that a "discrete cell location" or "predefined region" implied activation using an energy source (as used by Incyte) for both the '934 and '305 patents, the United States Patent and Trademark Office has recently allowed additional claims in Affymetrix' patent applications without this limitation. The Court's interpretation combined with the recent notices of allowance establish that Affymetrix' family of array patents covers arrays made by a wide variety of techniques for in situ synthesis and deposition of pre-formed polynucleotides Can anyone clarify ? nig